Women's experiences after abruptly stopping estrogen plus progestin in the Women's Health Initiative clinical trial

被引：0
|
作者：
Cooksey, SG [1 ]
Ritenbaugh, CK [1 ]
Valanis, BG [1 ]
Brandon, PL [1 ]
Siegel, NA [1 ]
Smith, PR [1 ]
Aickin, MG [1 ]
机构：
[1] Kaiser Permanente Ctr Hlth Res, Clin Serv, Portland, OR USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2003年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：569 / 569
页数：1
相关论文
共 50 条
  • [21] Non-small cell lung cancer and estrogen plus progestin use in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R. T.
    Schwartz, A.
    Wakelee, H.
    Anderson, G. L.
    Stefanick, M. L.
    Manson, J. E.
    Chien, J. W.
    Chen, C.
    Wactawski-Wende, J.
    Gass, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [22] Non-small cell lung cancer and estrogen plus progestin use in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R. T.
    Schwartz, A.
    Wakelee, H.
    Anderson, G. L.
    Stefanick, M. L.
    Manson, J. E.
    Chien, J. W.
    Chen, C.
    Wactawski-Wende, J.
    Gass, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] HEALTH STATE UTILITIES VALUES FOR POST-MENOPAUSAL WOMEN FROM THE WOMEN'S HEALTH INITIATIVE ESTROGEN plus PROGESTIN CLINCIAL TRIAL
    Roth, J.
    Pettinger, M.
    Anderson, G.
    Ramsey, S.
    VALUE IN HEALTH, 2013, 16 (03) : A75 - A76
  • [24] After the women's health initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy
    Haskell, SG
    JOURNAL OF WOMENS HEALTH, 2004, 13 (04) : 438 - 442
  • [25] Continuous combined oestrogen plus progestin and endometrial cancer in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R.
    Anderson, G. L.
    Sarto, G.
    Haque, R.
    Runowicz, C.
    Aragaki, A.
    Thomson, C. A.
    Howard, B. V.
    Reed, S.
    Manson, J. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S7
  • [26] Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
    Cauley, JA
    Robbins, J
    Chen, Z
    Cummings, SR
    Jackson, RD
    LaCroix, AZ
    LeBoff, M
    Lewis, CE
    McGowan, J
    Neuner, J
    Pettinger, M
    Stefanick, ML
    Wactawski-Wende, J
    Watts, NB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1729 - 1738
  • [27] Prior hormone therapy and breast cancer risk in the Women's Health initiative randomized trial of estrogen plus progestin
    Anderson, Garnet L.
    Chlebowski, Rowan T.
    Rossouw, Jacques E.
    Rodabough, Rebecca J.
    McTiernan, Anne
    Margolis, Karen L.
    Aggerwal, Anita
    Curb, J. David
    Hendrix, Susan L.
    Hubbell, F. Allan
    Khandekar, Jamardan
    Lane, Dorothy S.
    Lasser, Norman
    Lopez, Ana Maria
    Potter, JoNell
    Ritenbaugh, Cheryl
    MATURITAS, 2006, 55 (02) : 103 - 115
  • [28] Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings
    Nikolaenko, Liana
    Anderson, Garnet
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2013, 39 (03): : 226 - 228
  • [29] Hormone therapy and venous thrombosis: Final results of the Women's Health Initiative trial of estrogen plus progestin.
    Cushman, M
    Kuller, LH
    Prentice, R
    Psaty, BM
    Sidney, S
    Stafford, R
    Rodabough, R
    Rosendaal, FR
    BLOOD, 2003, 102 (11) : 208A - 208A
  • [30] Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial
    Anderson, GL
    Judd, HL
    Kaunitz, AM
    Barad, DH
    Beresford, SAA
    Pettinger, M
    Liu, J
    McNeeley, SG
    Lopez, AM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1739 - 1748
12345